Sharoev T A, Nechushkin M I, Ivanova N M, Durnov L A
Research Institute of Pediatric Oncology and Hematology, N.N. Blokhin Center for Oncology Research, Russian Academy of Medical Sciences, Moscow.
Vopr Onkol. 2000;46(4):448-52.
An analysis of 24-month relapse-free survival in 62 patients with rhabdomyosarcoma (S.I.O.P.-89) is presented. All children with rhabdomyosarcoma (RMS) stage I have survived; stage II--90, and stage III--62%, i.e. twice as many as compared with those treated before 1993. RMS sites included retroperitoneal space, spatium perinei, urinary bladder, testicle, abdominal and thoracic cavity. Diagnosis was based on clinical, instrumental, laboratory, X-ray, radionuclide, ultrasound and morphological data. Recommendations for examination of RMS suspects were worked out for different levels of expertise.
本文呈现了对62例横纹肌肉瘤患者(S.I.O.P.-89)24个月无复发生存率的分析。所有I期横纹肌肉瘤(RMS)患儿均存活;II期患儿的生存率为90%,III期为62%,即与1993年前接受治疗的患儿相比,生存率提高了一倍。RMS的发病部位包括腹膜后间隙、会阴间隙、膀胱、睾丸、腹腔和胸腔。诊断基于临床、仪器检查、实验室、X线、放射性核素、超声和形态学数据。针对不同专业水平制定了对疑似RMS患者的检查建议。